FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000685605> ?p ?o ?g. }

• W3000685605 endingPage "39" @default.
• W3000685605 startingPage "29" @default.
• W3000685605 abstract "We suggested: 1) patients with idiopathic pulmonary hypertension (IPAH) have active factors which could damage not only the pulmonary but systemic arteries too as in arterial hypertensive patients; 2) if these changes were present, they might correlate with other parameters influencing on the prognosis. This study is the first attempt to use cardio-ankle vascular index (CAVI) for the evaluation of systemic arterial stiffness in patients with IPAH.A total of 112 patients were included in the study: group 1 consisted of 45 patients with new diagnosed IPAH, group 2 included 32 patients with arterial hypertension, and in the control group were 35 healthy persons adjusted by age. Right heart catheterization, ECG, a 6-minute walk test (6MWT), echocardiography, blood pressure (BP) measurement and ambulatory BP monitoring, pulse wave elastic artery stiffness (PWVe; segment carotid-femoral arteries) and muscular artery stiffness (PWVm; segment carotid-radial arteries), CAVI, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) level were provided. The Spearman correlation, a linear regression and multivariable binary logistic analysis were performed to indicate the predictors associated with PWV and CAVI.The groups were adjusted for principal characteristics influenced on arterial stiffness. IPAH patients had significantly (P<0.001 for all) shorter 6MWT distance and higher Borg dyspnea score than the patients with arterial hypertension (systolic/diastolic BP = 146.1±10.7/94.2±9.8 mmHg) and the control group = 330.2±14.6 vs 523.8±35.3 and 560.9±30.2 m respectively and 6.2±1.8 vs 1.2±2.1 and 0.9±2.8 points. The PWVm and PWVe were the highest in hypertensive patients (10.3±1.5 and 11.42±1.70 m/s). The control group and IPAH did not have significant differences in aorta BP, but PWVm/PWVe values were significantly (P<0.003/0.008) higher in IPAH patients than in the control group (8.1±1.9/8.49±1.92 vs 6.63±1.34/7.29±0.87 m/s). The CAVIs on both sides were significantly lower in the healthy subjects (5.91±0.99/5.98±0.87 right/left side). Patients with IPAH did not differ from the arterial hypertension patients by CAVIs in comparison with the control group (7.40±1.32/7.22±1.32 vs 7.19±0.78/7.2±1.1 PWVe) did not correlate with any parameters except uric acid. PWVm correlated with uric acid (r=0.58, P<0.001), NT-proBNP (r=0.33, P=0.03) and male gender (r=0.37, P=0.013) at Spearman analysis, but not at multifactorial linear regression analysis. The CAVI correlated with age and parameters characterized functional capacity (6MWT distance) and right ventricle function (NT-proBNP, TAPSE) at Spearman analysis and with age and TAPSE at multifactorial linear regression analysis. At binary logistic regression analysis CAVI > 8.0 at right and/or left side had a correlation with age, 6MWT distance, TAPSE, but an independent correlation was only with age (β=1.104, P=0.008, CI 1.026-1.189) and TAPSE (β=0.66, P=0.016, CI 0.474-0.925).In spite of equal and at normal range BP level, the age-adjusted patients with IPAH had significantly stiffer arteries than the healthy persons and they were comparable with the arterial hypertensive patients. Arterial stiffness evaluated by CAVI correlated with age and TAPSE in IPAH patients. Based on our results it is impossible to conclude the pathogenesis of arterial stiffening in IPAH patients, but the discovered changes and correlations suggest new directions for further studies, including pathogenesis and prognosis researches." @default.
• W3000685605 created "2020-01-23" @default.
• W3000685605 creator A5040924418 @default.
• W3000685605 creator A5085456956 @default.
• W3000685605 creator A5085496157 @default.
• W3000685605 creator A5056310074 @default.
• W3000685605 date "2020-01-01" @default.
• W3000685605 modified "2023-09-26" @default.
• W3000685605 title "<p>Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients</p>" @default.
• W3000685605 cites W122349615 @default.
• W3000685605 cites W1514239588 @default.
• W3000685605 cites W1546492882 @default.
• W3000685605 cites W1580787210 @default.
• W3000685605 cites W1964684124 @default.
• W3000685605 cites W1984542647 @default.
• W3000685605 cites W1986888801 @default.
• W3000685605 cites W2000314052 @default.
• W3000685605 cites W2004996094 @default.
• W3000685605 cites W2014295218 @default.
• W3000685605 cites W2015183732 @default.
• W3000685605 cites W2024027178 @default.
• W3000685605 cites W2030300717 @default.
• W3000685605 cites W2032885711 @default.
• W3000685605 cites W2042141267 @default.
• W3000685605 cites W2042273019 @default.
• W3000685605 cites W2044346818 @default.
• W3000685605 cites W2058876846 @default.
• W3000685605 cites W2059107906 @default.
• W3000685605 cites W2070079263 @default.
• W3000685605 cites W2070711758 @default.
• W3000685605 cites W2071010874 @default.
• W3000685605 cites W2078242797 @default.
• W3000685605 cites W2090873886 @default.
• W3000685605 cites W2099912088 @default.
• W3000685605 cites W2106403351 @default.
• W3000685605 cites W2109232495 @default.
• W3000685605 cites W2113473672 @default.
• W3000685605 cites W2117339256 @default.
• W3000685605 cites W2123263258 @default.
• W3000685605 cites W2124624517 @default.
• W3000685605 cites W2125263078 @default.
• W3000685605 cites W2131599914 @default.
• W3000685605 cites W2133416234 @default.
• W3000685605 cites W2133936093 @default.
• W3000685605 cites W2136545964 @default.
• W3000685605 cites W2140655158 @default.
• W3000685605 cites W2141262339 @default.
• W3000685605 cites W2144120465 @default.
• W3000685605 cites W2144681715 @default.
• W3000685605 cites W2150534880 @default.
• W3000685605 cites W2151834039 @default.
• W3000685605 cites W2155504581 @default.
• W3000685605 cites W2157601642 @default.
• W3000685605 cites W2160056424 @default.
• W3000685605 cites W2161370807 @default.
• W3000685605 cites W2161841978 @default.
• W3000685605 cites W2161924597 @default.
• W3000685605 cites W2258190478 @default.
• W3000685605 cites W2283619910 @default.
• W3000685605 cites W2334006336 @default.
• W3000685605 cites W2398485227 @default.
• W3000685605 cites W2411415247 @default.
• W3000685605 cites W2429321598 @default.
• W3000685605 cites W2503884223 @default.
• W3000685605 cites W2549628735 @default.
• W3000685605 cites W2614800967 @default.
• W3000685605 cites W2730973491 @default.
• W3000685605 cites W2738950469 @default.
• W3000685605 cites W2751105354 @default.
• W3000685605 cites W2789769541 @default.
• W3000685605 cites W2807970119 @default.
• W3000685605 cites W2884830729 @default.
• W3000685605 cites W2889922202 @default.
• W3000685605 cites W2889936242 @default.
• W3000685605 cites W2925659083 @default.
• W3000685605 cites W2940843649 @default.
• W3000685605 cites W4214833830 @default.
• W3000685605 cites W4245666729 @default.
• W3000685605 doi "https://doi.org/10.2147/vhrm.s230041" @default.
• W3000685605 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6971813" @default.
• W3000685605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32021226" @default.
• W3000685605 hasPublicationYear "2020" @default.
• W3000685605 type Work @default.
• W3000685605 sameAs 3000685605 @default.
• W3000685605 citedByCount "9" @default.
• W3000685605 countsByYear W30006856052021 @default.
• W3000685605 countsByYear W30006856052022 @default.
• W3000685605 crossrefType "journal-article" @default.
• W3000685605 hasAuthorship W3000685605A5040924418 @default.
• W3000685605 hasAuthorship W3000685605A5056310074 @default.
• W3000685605 hasAuthorship W3000685605A5085456956 @default.
• W3000685605 hasAuthorship W3000685605A5085496157 @default.
• W3000685605 hasBestOaLocation W30006856051 @default.
• W3000685605 hasConcept C126322002 @default.
• W3000685605 hasConcept C149323552 @default.
• W3000685605 hasConcept C164705383 @default.
• W3000685605 hasConcept C2775850156 @default.
• W3000685605 hasConcept C2775915353 @default.

• next